- Published on
Emergency and Acute Medicine – Cardiogenic Shock
Core Concept
Cardiogenic shock is defined by sustained hypotension and systemic hypoperfusion resulting from primary cardiac pump failure despite adequate intravascular volume and left ventricular filling pressures. It remains the leading cause of in-hospital mortality in patients with acute myocardial infarction (AMI). Approximately 5–8% of patients with STEMI develop cardiogenic shock. Pathophysiology includes severe LV dysfunction (often ≥40% infarction), infarction superimposed on chronic LV disease, reinfarction, mechanical complications (acute mitral regurgitation, ventricular septal rupture, free wall rupture with tamponade), and right ventricular infarction. A systemic inflammatory response with excess nitric oxide may worsen vasodilation and myocardial depression. Early β-blocker, ACE inhibitor, or aggressive diuretic use may contribute to shock development in vulnerable patients.
Underlying Causes
Acute myocardial infarction
Sepsis
Myocarditis
Myocardial contusion
Valvular heart disease
Dilated or ischemic cardiomyopathy
Left atrial myxoma
Drug toxicity (β-blockers, calcium channel blockers, anthracyclines)
Clinical Presentation
Airway and breathing findings include early tachypnea and labored respirations progressing to respiratory failure, diffuse crackles or wheezing, and hypoxia. Circulatory findings include systolic blood pressure <90 mm hg or a ≥30 drop from baseline, tachycardia, weak pulses, oliguria (<20 ml />r), cyanosis, pallor, diaphoresis, altered mental status, and hypothermia. Jugular venous distention is common. Cardiac findings may include ischemic chest pain, apical systolic murmur (acute MR), gallop rhythm (S3 indicating severe LV dysfunction; S4 common in AMI with sinus rhythm), or a systolic click suggesting papillary muscle or chordal rupture. GI symptoms include epigastric pain, nausea, and vomiting. Neurologic findings include obtundation or confusion. History should be obtained rapidly from patient, family, or EMS, focusing on cardiac risk factors and medication use. Physical exam emphasizes differentiation from distributive or hypovolemic shock; cool extremities with elevated JVP favor cardiogenic shock.
Initial Evaluation Priorities
Diagnostic studies help define the extent of myocardial injury and identify candidates for urgent catheterization or surgery.
Key Diagnostics
Electrocardiogram may show ST-elevation MI, NSTEMI patterns, dysrhythmias, or LV hypertrophy; a normal ECG does not exclude AMI. Laboratory tests include troponin, CK/CK-MB, BNP (diagnostic and prognostic), electrolytes, renal function (acute kidney injury strongly predicts mortality), CBC, and relevant drug levels (e.g., digoxin). Chest radiograph may demonstrate pulmonary edema, pleural effusions, cardiomegaly, pneumonia, pneumothorax, or pericardial effusion. Emergent transthoracic echocardiography with Doppler is critical to assess LV function, wall-motion abnormalities, acute MR or septal defects, RV size and function (RV infarction vs pulmonary embolism), and pericardial tamponade.
Important Differentials
Obstructive shock: tension pneumothorax, cardiac tamponade, pulmonary embolism, air embolism, esophageal rupture
Distributive shock: sepsis, anaphylaxis, adrenal crisis, neurogenic shock
Hypovolemic shock: hemorrhage, dehydration, GI losses, burns
Prehospital Management
Immediate airway, oxygen, IV access, and monitoring. Consider cautious fluid bolus if lungs are clear. Administer aspirin. Use nitroglycerin or morphine for ischemic pain only if hypotension is absent. Transport AMI patients to centers with 24-hour revascularization capability.
Early Stabilization in the ED
Secure airway and provide ventilatory support as needed; etomidate is preferred for induction due to minimal hemodynamic effect. Establish two large-bore IV lines and continuous cardiac monitoring. Administer a cautious fluid challenge (100–250 mL NS) if no pulmonary congestion. Insert Foley catheter for urine output monitoring.
Definitive Emergency Management
For AMI, initiate aspirin and heparin, consider thrombolysis if PCI or CABG unavailable, and use GP IIb/IIIa inhibitors when appropriate prior to PCI. Norepinephrine is the first-line vasopressor for hypotension; dopamine may be used if norepinephrine is unavailable. In normotensive patients with low cardiac output, dobutamine may be added, sometimes combined with nitroprusside in acute MR. Milrinone may be considered as adjunctive in selected cases. Pulmonary edema in normotensive patients may be treated with nitroglycerin infusion or diuretics. Early cardiology consultation is essential; intra-aortic balloon pump support can improve survival in experienced centers. Early revascularization is the single most effective life-saving intervention.
Common Medications
Dobutamine 3–5 μg/kg/min IV, titrate as needed
Dopamine 3–5 μg/kg/min IV, titrate as needed
Norepinephrine starting at 2 μg/min IV, titrate to MAP
Nitroglycerin 10–20 μg/min IV (non-PVC tubing)
Milrinone loading 50 μg/kg, then 0.375–0.75 μg/kg/min IV
Furosemide 40–80 mg IV (if appropriate)
Nitroprusside 0.3 μg/kg/min IV, titrate cautiously
Disposition
All patients with cardiogenic shock require admission to an intensive care unit.
Clinical Takeaways
Cardiogenic shock is the most common cause of death in hospitalized AMI patients. Early identification of preshock states, rapid hemodynamic support, and prompt revascularization dramatically improve outcomes.
Core Concept
Cardiogenic shock is defined by sustained hypotension and systemic hypoperfusion resulting from primary cardiac pump failure despite adequate intravascular volume and left ventricular filling pressures. It remains the leading cause of in-hospital mortality in patients with acute myocardial infarction (AMI). Approximately 5–8% of patients with STEMI develop cardiogenic shock. Pathophysiology includes severe LV dysfunction (often ≥40% infarction), infarction superimposed on chronic LV disease, reinfarction, mechanical complications (acute mitral regurgitation, ventricular septal rupture, free wall rupture with tamponade), and right ventricular infarction. A systemic inflammatory response with excess nitric oxide may worsen vasodilation and myocardial depression. Early β-blocker, ACE inhibitor, or aggressive diuretic use may contribute to shock development in vulnerable patients.
Underlying Causes
Acute myocardial infarction
Sepsis
Myocarditis
Myocardial contusion
Valvular heart disease
Dilated or ischemic cardiomyopathy
Left atrial myxoma
Drug toxicity (β-blockers, calcium channel blockers, anthracyclines)
Clinical Presentation
Airway and breathing findings include early tachypnea and labored respirations progressing to respiratory failure, diffuse crackles or wheezing, and hypoxia. Circulatory findings include systolic blood pressure <90 mm hg or a ≥30 drop from baseline, tachycardia, weak pulses, oliguria (<20 ml />r), cyanosis, pallor, diaphoresis, altered mental status, and hypothermia. Jugular venous distention is common. Cardiac findings may include ischemic chest pain, apical systolic murmur (acute MR), gallop rhythm (S3 indicating severe LV dysfunction; S4 common in AMI with sinus rhythm), or a systolic click suggesting papillary muscle or chordal rupture. GI symptoms include epigastric pain, nausea, and vomiting. Neurologic findings include obtundation or confusion. History should be obtained rapidly from patient, family, or EMS, focusing on cardiac risk factors and medication use. Physical exam emphasizes differentiation from distributive or hypovolemic shock; cool extremities with elevated JVP favor cardiogenic shock.
Initial Evaluation Priorities
Diagnostic studies help define the extent of myocardial injury and identify candidates for urgent catheterization or surgery.
Key Diagnostics
Electrocardiogram may show ST-elevation MI, NSTEMI patterns, dysrhythmias, or LV hypertrophy; a normal ECG does not exclude AMI. Laboratory tests include troponin, CK/CK-MB, BNP (diagnostic and prognostic), electrolytes, renal function (acute kidney injury strongly predicts mortality), CBC, and relevant drug levels (e.g., digoxin). Chest radiograph may demonstrate pulmonary edema, pleural effusions, cardiomegaly, pneumonia, pneumothorax, or pericardial effusion. Emergent transthoracic echocardiography with Doppler is critical to assess LV function, wall-motion abnormalities, acute MR or septal defects, RV size and function (RV infarction vs pulmonary embolism), and pericardial tamponade.
Important Differentials
Obstructive shock: tension pneumothorax, cardiac tamponade, pulmonary embolism, air embolism, esophageal rupture
Distributive shock: sepsis, anaphylaxis, adrenal crisis, neurogenic shock
Hypovolemic shock: hemorrhage, dehydration, GI losses, burns
Prehospital Management
Immediate airway, oxygen, IV access, and monitoring. Consider cautious fluid bolus if lungs are clear. Administer aspirin. Use nitroglycerin or morphine for ischemic pain only if hypotension is absent. Transport AMI patients to centers with 24-hour revascularization capability.
Early Stabilization in the ED
Secure airway and provide ventilatory support as needed; etomidate is preferred for induction due to minimal hemodynamic effect. Establish two large-bore IV lines and continuous cardiac monitoring. Administer a cautious fluid challenge (100–250 mL NS) if no pulmonary congestion. Insert Foley catheter for urine output monitoring.
Definitive Emergency Management
For AMI, initiate aspirin and heparin, consider thrombolysis if PCI or CABG unavailable, and use GP IIb/IIIa inhibitors when appropriate prior to PCI. Norepinephrine is the first-line vasopressor for hypotension; dopamine may be used if norepinephrine is unavailable. In normotensive patients with low cardiac output, dobutamine may be added, sometimes combined with nitroprusside in acute MR. Milrinone may be considered as adjunctive in selected cases. Pulmonary edema in normotensive patients may be treated with nitroglycerin infusion or diuretics. Early cardiology consultation is essential; intra-aortic balloon pump support can improve survival in experienced centers. Early revascularization is the single most effective life-saving intervention.
Common Medications
Dobutamine 3–5 μg/kg/min IV, titrate as needed
Dopamine 3–5 μg/kg/min IV, titrate as needed
Norepinephrine starting at 2 μg/min IV, titrate to MAP
Nitroglycerin 10–20 μg/min IV (non-PVC tubing)
Milrinone loading 50 μg/kg, then 0.375–0.75 μg/kg/min IV
Furosemide 40–80 mg IV (if appropriate)
Nitroprusside 0.3 μg/kg/min IV, titrate cautiously
Disposition
All patients with cardiogenic shock require admission to an intensive care unit.
Clinical Takeaways
Cardiogenic shock is the most common cause of death in hospitalized AMI patients. Early identification of preshock states, rapid hemodynamic support, and prompt revascularization dramatically improve outcomes.
0 Comments
